0001628280-24-000693.txt : 20240105 0001628280-24-000693.hdr.sgml : 20240105 20240105172947 ACCESSION NUMBER: 0001628280-24-000693 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240104 FILED AS OF DATE: 20240105 DATE AS OF CHANGE: 20240105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lewis William CENTRAL INDEX KEY: 0001402051 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30739 FILM NUMBER: 24517627 MAIL ADDRESS: STREET 1: 10 FINDERNE AVENUE STREET 2: BUILDING 10 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSMED Inc CENTRAL INDEX KEY: 0001104506 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 541972729 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908-977-9900 MAIL ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: INSMED INC DATE OF NAME CHANGE: 20000128 4 1 wk-form4_1704493778.xml FORM 4 X0508 4 2024-01-04 0 0001104506 INSMED Inc INSM 0001402051 Lewis William 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 1 1 0 0 Chair and CEO 0 Common Stock 2024-01-04 4 A 0 37869 A 380517 D Common Stock 2024-01-05 4 S 0 6979 29.2585 D 373538 D Common Stock 233924 I By ARTICLE 4 KATIE PROCTER DYNASTY TRUST Common Stock 500 I By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020 Stock Option (right to buy) 29.13 2024-01-04 4 A 0 186970 0 A 2034-01-04 Common Stock 186970 186970 D Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant. Each Restricted Stock Unit was received as a grant on January 4, 2024, for no consideration. Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. This is the weighted average sales price representing 6,979 shares sold at prices ranging from $29.24 to $29.26 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Stock options granted under the Company's Amended and Restated 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. /s/ William H. Lewis, by Michael Smith as Attorney in Fact 2024-01-05